Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 56 articles:
HTML format
Text format



Single Articles


    May 2017
  1. XIE K, Chen M, Zhu M, Wang C, et al
    A polymorphism in miR-1262 regulatory region confers the risk of lung cancer in Chinese population.
    Int J Cancer. 2017 May 16. doi: 10.1002/ijc.30788.
    PubMed     Text format     Abstract available


  2. NAJMEH S, Cools-Lartigue J, Rayes RF, Gowing S, et al
    Neutrophil extracellular traps sequester circulating tumor cells via beta1-integrin mediated interactions.
    Int J Cancer. 2017;140:2321-2330.
    PubMed     Text format     Abstract available


  3. MEYERS TJ, Chang SC, Chang PY, Morgenstern H, et al
    Case-control study of cumulative cigarette tar exposure and lung and upper aerodigestive tract cancers.
    Int J Cancer. 2017;140:2040-2050.
    PubMed     Text format     Abstract available


    April 2017
  4. LOBB RJ, van Amerongen R, Wiegmans A, Ham S, et al
    Exosomes derived from mesenchymal non-small cell lung cancer cells promote chemoresistance.
    Int J Cancer. 2017 Apr 26. doi: 10.1002/ijc.30752.
    PubMed     Text format     Abstract available


  5. BEN KHEDHER S, Neri M, Papadopoulos A, Christiani DC, et al
    Menstrual and reproductive factors and lung cancer risk: A pooled analysis from the International Lung Cancer consortium (ILCCO).
    Int J Cancer. 2017 Apr 25. doi: 10.1002/ijc.30750.
    PubMed     Text format     Abstract available


  6. WANG SS, Zimmermann M, Zhang H, Lin TY, et al
    A Diagnostic Microdosing Approach to Investigate Platinum Sensitivity in Non-Small Cell Lung Cancer.
    Int J Cancer. 2017 Apr 24. doi: 10.1002/ijc.30747.
    PubMed     Text format     Abstract available


  7. GROMOWSKI T, Gapska P, Scott RJ, Kaklewski K, et al
    Serum 25(OH)D concentration, common variants of the VDR gene and lung cancer occurrence.
    Int J Cancer. 2017 Apr 15. doi: 10.1002/ijc.30740.
    PubMed     Text format     Abstract available


  8. GOWING SD, Chow SC, Cools-Lartigue JJ, Chen CB, et al
    Gram-Positive Pneumonia Augments Non-Small Cell Lung Cancer Metastasis Via Host Toll-like Receptor 2 Activation.
    Int J Cancer. 2017 Apr 12. doi: 10.1002/ijc.30734.
    PubMed     Text format     Abstract available


  9. CAROZZI FM, Bisanzi S, Carrozzi L, Falaschi F, et al
    Multimodal lung cancer screening using the ITALUNG Biomarker Panel and Low Dose Computed Tomography. Results of the ITALUNG biomarker study.
    Int J Cancer. 2017 Apr 7. doi: 10.1002/ijc.30727.
    PubMed     Text format     Abstract available


  10. HELLAND A, Brustugun OT, Nakken S, Halvorsen AR, et al
    High number of kinome-mutations in non-small cell lung cancer is associated with reduced immune response and poor relapse-free survival.
    Int J Cancer. 2017 Apr 7. doi: 10.1002/ijc.30726.
    PubMed     Text format     Abstract available


  11. LIN J, Gill A, Zahm SH, Carter CA, et al
    Metformin Use and Survival after Non-Small Cell Lung Cancer: A Cohort Study in the U.S. Military Health System.
    Int J Cancer. 2017 Apr 5. doi: 10.1002/ijc.30724.
    PubMed     Text format     Abstract available


  12. FRANK C, Sundquist J, Yu H, Hemminki A, et al
    Concordant and discordant familial cancer: Familial risks, proportions and population impact.
    Int J Cancer. 2017;140:1510-1516.
    PubMed     Text format     Abstract available


  13. RAASCHOU-NIELSEN O, Pedersen M, Stafoggia M, Weinmayr G, et al
    Outdoor air pollution and risk for kidney parenchyma cancer in 14 European cohorts.
    Int J Cancer. 2017;140:1528-1537.
    PubMed     Text format     Abstract available


  14. TANG Z, Li J, Shen Q, Feng J, et al
    Contribution of upregulated dipeptidyl peptidase 9 (DPP9) in promoting tumoregenicity, metastasis and the prediction of poor prognosis in non-small cell lung cancer (NSCLC).
    Int J Cancer. 2017;140:1620-1632.
    PubMed     Text format     Abstract available


    March 2017
  15. DONG J, Cheng Y, Zhu M, Wen Y, et al
    Fine Mapping of Chromosome 5p15.33 Identifies Novel Lung Cancer Susceptibility Loci in Han Chinese.
    Int J Cancer. 2017 Mar 23. doi: 10.1002/ijc.30702.
    PubMed     Text format     Abstract available


  16. YANG Z, Hackshaw A, Feng Q, Fu X, et al
    Comparison of gefitinib, erlotinib and afatinib in non-small cell lung cancer: A meta-analysis.
    Int J Cancer. 2017 Mar 14. doi: 10.1002/ijc.30691.
    PubMed     Text format     Abstract available


  17. WEBER M, Yap S, Goldsbury D, Manners D, et al
    Identifying high risk individuals for targeted lung cancer screening: Independent validation of the PLCOM2012 risk prediction tool.
    Int J Cancer. 2017 Mar 1. doi: 10.1002/ijc.30673.
    PubMed     Text format     Abstract available


    February 2017
  18. SHIEH JM, Tang YA, Hu FH, Huang WJ, et al
    A histone deacetylase inhibitor enhances expression of genes inhibiting Wnt pathway and augments activity of DNA demethylation reagent against non-small cell lung cancer.
    Int J Cancer. 2017 Feb 24. doi: 10.1002/ijc.30664.
    PubMed     Text format     Abstract available


  19. LIN TY, Hsu HY, Sun WH, Wu TH, et al
    Induction of Cbl-dependent epidermal growth factor receptor degradation in Ling Zhi-8 suppressed lung cancer.
    Int J Cancer. 2017 Feb 15. doi: 10.1002/ijc.30649.
    PubMed     Text format     Abstract available


    January 2017
  20. FEHRINGER G, Brenner DR, Zhang ZF, Lee YA, et al
    Alcohol and Lung Cancer Risk Among Never Smokers: A Pooled Analysis from the International Lung Cancer Consortium and the SYNERGY Study.
    Int J Cancer. 2017 Jan 24. doi: 10.1002/ijc.30618.
    PubMed     Text format     Abstract available


  21. HAN SS, Ten Haaf K, Hazelton WD, Munshi VN, et al
    The impact of overdiagnosis on the selection of efficient lung cancer screening strategies.
    Int J Cancer. 2017 Jan 10. doi: 10.1002/ijc.30602.
    PubMed     Text format     Abstract available


  22. ZHANG LL, Kan M, Zhang MM, Yu SS, et al
    Multiregion sequencing reveals the intratumor heterogeneity of driver mutations in TP53-driven non-small cell lung cancer.
    Int J Cancer. 2017;140:103-108.
    PubMed     Text format     Abstract available


  23. KAMMERER-JACQUET SF, Crouzet L, Brunot A, Dagher J, et al
    Independent association of PD-L1 expression with noninactivated VHL clear cell renal cell carcinoma-A finding with therapeutic potential.
    Int J Cancer. 2017;140:142-148.
    PubMed     Text format     Abstract available


  24. VAZQUEZ R, Licandro SA, Astorgues-Xerri L, Lettera E, et al
    Promising in vivo efficacy of the BET bromodomain inhibitor OTX015/MK-8628 in malignant pleural mesothelioma xenografts.
    Int J Cancer. 2017;140:197-207.
    PubMed     Text format     Abstract available


    December 2016
  25. ZHANG Y, Xu J, Lou Y, Hu S, et al
    Pretreatment Direct Bilirubin and Total Cholesterol Are Significant Predictors of Overall Survival in Advanced Non-small Cell Lung Cancer Patients with EGFR Mutations.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30581.
    PubMed     Text format     Abstract available


  26. MANDRIOTA SJ, Tenan M, Ferrari P, Sappino AP, et al
    Aluminium chloride promotes tumorigenesis and metastasis in normal murine mammary gland epithelial cells.
    Int J Cancer. 2016;139:2781-2790.
    PubMed     Text format     Abstract available


    November 2016
  27. POON CC, Kelly JJ
    Development of crizotinib, a rationally designed tyrosine kinase inhibitor for non-small cell lung cancer.
    Int J Cancer. 2016 Nov 22. doi: 10.1002/ijc.30533.
    PubMed     Text format     Abstract available


  28. LI L, Yang L, Wang L, Wang F, et al
    Impaired T cell function in malignant pleural effusion is caused by TGF-beta derived predominantly from macrophages.
    Int J Cancer. 2016;139:2261-9.
    PubMed     Text format     Abstract available


  29. NAGY A, Pongor LS, Szabo A, Santarpia M, et al
    KRAS driven expression signature has prognostic power superior to mutation status in non-small cell lung cancer.
    Int J Cancer. 2016 Nov 8. doi: 10.1002/ijc.30509.
    PubMed     Text format     Abstract available


  30. JIA M, Zhu M, Zhou F, Wang M, et al
    Genetic variants of JNK and p38alpha pathways and risk of non-small cell lung cancer in an Eastern Chinese population.
    Int J Cancer. 2016 Nov 5. doi: 10.1002/ijc.30508.
    PubMed     Text format     Abstract available


    October 2016
  31. PEREA F, Bernal M, Sanchez-Palencia A, Carretero J, et al
    The absence of HLA class I expression in non-small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration.
    Int J Cancer. 2016 Oct 27. doi: 10.1002/ijc.30489.
    PubMed     Text format     Abstract available


  32. TRABERT B, Eldridge RC, Pfeiffer RM, Shiels MS, et al
    Pre-diagnostic circulating inflammation markers and endometrial cancer risk in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial.
    Int J Cancer. 2016 Oct 22. doi: 10.1002/ijc.30478.
    PubMed     Text format     Abstract available


  33. WANG D, Pham NA, Tong J, Sakashita S, et al
    Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.
    Int J Cancer. 2016 Oct 17. doi: 10.1002/ijc.30472.
    PubMed     Text format     Abstract available


    September 2016
  34. OHYAMA K, Yoshimi H, Aibara N, Nakamura Y, et al
    Immune complexome analysis reveals the specific and frequent presence of immune complex antigens in lung cancer patients: A pilot study.
    Int J Cancer. 2016 Sep 29. doi: 10.1002/ijc.30455.
    PubMed     Text format     Abstract available


  35. BAGLIETTO L, Ponzi E, Haycock P, Hodge A, et al
    DNA methylation changes measured in pre-diagnostic peripheral blood samples are associated with smoking and lung cancer risk.
    Int J Cancer. 2016 Sep 15. doi: 10.1002/ijc.30431.
    PubMed     Text format     Abstract available


    August 2016
  36. HONG S, Mok Y, Jeon C, Jee SH, et al
    Tuberculosis, smoking and risk for lung cancer incidence and mortality.
    Int J Cancer. 2016 Aug 13. doi: 10.1002/ijc.30384.
    PubMed     Text format     Abstract available


  37. ZHANG Y, Breitling LP, Balavarca Y, Holleczek B, et al
    Comparison and combination of blood DNA methylation at smoking-associated genes and at lung cancer related genes in prediction of lung cancer mortality.
    Int J Cancer. 2016 Aug 9. doi: 10.1002/ijc.30374.
    PubMed     Text format     Abstract available


    July 2016
  38. WANG A, Qin F, Hedlin H, Desai M, et al
    Physical activity and sedentary behavior in relation to lung cancer incidence and mortality in older women: The Women's Health Initiative.
    Int J Cancer. 2016 Jul 20. doi: 10.1002/ijc.30281.
    PubMed     Text format     Abstract available


  39. TOMCZAK A, Miller AB, Weichenthal SA, To T, et al
    Long-term exposure to fine particulate matter air pollution and the risk of lung cancer among participants of the Canadian National Breast Screening Study.
    Int J Cancer. 2016 Jul 6. doi: 10.1002/ijc.30255.
    PubMed     Text format     Abstract available


  40. ZHAO QT, Yuan Z, Zhang H, Zhang XP, et al
    Prognostic role of platelet to lymphocyte ratio in non-small cell lung cancers: A meta-analysis including 3,720 patients.
    Int J Cancer. 2016;139:164-70.
    PubMed     Text format     Abstract available


  41. YANG M, Xu X, Cai J, Ning J, et al
    NSCLC harboring EGFR exon-20 insertions after the regulatory C-helix of kinase domain responds poorly to known EGFR inhibitors.
    Int J Cancer. 2016;139:171-6.
    PubMed     Text format     Abstract available


    June 2016
  42. WANG J, Su X, Yang L, Qiao F, et al
    The influence of myeloid-derived suppressor cells on angiogenesis and tumor growth after cancer surgery.
    Int J Cancer. 2016;138:2688-99.
    PubMed     Text format     Abstract available


    May 2016
  43. XIE K, Liang C, Li Q, Yan C, et al
    Role of ATG10 expression quantitative trait loci in non-small cell lung cancer survival.
    Int J Cancer. 2016 May 26. doi: 10.1002/ijc.30205.
    PubMed     Text format     Abstract available


    April 2016
  44. AIZAWA K, Liu C, Tang S, Veeramachaneni S, et al
    Tobacco carcinogen (NNK) induces both lung cancer and non-alcoholic steatohepatitis and hepatocellular carcinomas in ferrets which can be attenuated by lycopene supplementation.
    Int J Cancer. 2016 Apr 26. doi: 10.1002/ijc.30161.
    PubMed     Text format     Abstract available


    March 2016
  45. PIRIE K, Peto R, Green J, Reeves GK, et al
    Lung cancer in never-smokers.
    Int J Cancer. 2016 Mar 8. doi: 10.1002/ijc.30084.
    PubMed     Text format     Abstract available


    February 2016
  46. MEDER L, Konig K, Ozretic L, Schultheis AM, et al
    NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas.
    Int J Cancer. 2016;138:927-38.
    PubMed     Text format     Abstract available


    January 2016
  47. JANG YS, Kang JH, Woo JK, Kim HM, et al
    Ninjurin1 suppresses metastatic property of lung cancer cells through inhibition of Interleukin-6 signaling pathway.
    Int J Cancer. 2016 Jan 27. doi: 10.1002/ijc.30021.
    PubMed     Text format     Abstract available


  48. WANG Y, Liu H, Ready NE, Su L, et al
    Genetic variants in ABCG1 are associated with survival of non-small cell lung cancer patients.
    Int J Cancer. 2016 Jan 12. doi: 10.1002/ijc.29991.
    PubMed     Text format     Abstract available


  49. MAHALE J, Smagurauskaite G, Brown K, Thomas A, et al
    The role of stromal fibroblasts in lung carcinogenesis: A target for chemoprevention?
    Int J Cancer. 2016;138:30-44.
    PubMed     Text format     Abstract available


    December 2015
  50. ZHANG X, Ai F, Li X, She X, et al
    Inflammation-induced S100A8 activates Id3 and promotes colorectal tumorigenesis.
    Int J Cancer. 2015;137:2803-14.
    PubMed     Text format     Abstract available


  51. YAMADA K, Maishi N, Akiyama K, Towfik Alam M, et al
    CXCL12-CXCR7 axis is important for tumor endothelial cell angiogenic property.
    Int J Cancer. 2015;137:2825-36.
    PubMed     Text format     Abstract available


  52. DAL BELLO MG, Alama A, Barletta G, Coco S, et al
    Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors.
    Int J Cancer. 2015;137:2947-58.
    PubMed     Text format     Abstract available


  53. YUAN JM, Nelson HH, Butler LM, Carmella SG, et al
    Genetic determinants of cytochrome P450 2A6 activity and biomarkers of tobacco smoke exposure in relation to risk of lung cancer development in the Shanghai Cohort Study.
    Int J Cancer. 2015 Dec 13. doi: 10.1002/ijc.29963.
    PubMed     Text format     Abstract available


  54. KJAERGAARD AD, Nordestgaard BG, Johansen JS, Bojesen SE, et al
    Observational and genetic plasma YKL-40 and cancer in 96,099 individuals from the general population.
    Int J Cancer. 2015;137:2696-704.
    PubMed     Text format     Abstract available


    May 2015
  55. BAI R, Weng C, Dong H, Li S, et al
    MicroRNA-409-3p suppresses colorectal cancer invasion and metastasis partly by targeting GAB1 expression.
    Int J Cancer. 2015 May 20. doi: 10.1002/ijc.29607.
    PubMed     Text format     Abstract available


  56. HLEYHEL M, Belot A, Bouvier AM, Tattevin P, et al
    Trends in survival after cancer diagnosis among HIV-Infected Individuals between 1992 and 2009. Results from the FHDH-ANRS CO4 Cohort.
    Int J Cancer. 2015 May 14. doi: 10.1002/ijc.29603.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: